Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular diagnostics of solid malignant tumours.

Burkhard H Brandt1

  • 1brandt@uni-muenster.de

Clinical Laboratory
|December 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RE: Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

Journal of the National Cancer Institute·2020
Same author

Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk.

Cell communication and signaling : CCS·2012
Same author

The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.

The Journal of pathology·2012
Same author

Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells.

Clinical & experimental metastasis·2010
Same author

Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.

Journal of proteome research·2010
Same author

Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/ progenitor cell protein profile.

Journal of proteome research·2009
Same journal

Profilin-1 as a Potential Biomarker in Acute Ischemic Stroke: Predictive Value for Large Vessel Occlusion and Mechanical Thrombectomy.

Clinical laboratory·2026
Same journal

Soluble Thrombomodulin can Predict In-Hospital Mortality of Community-Acquired Pneumonia Patients in Intensive Care Unit.

Clinical laboratory·2026
Same journal

Cytomegalovirus Seroprevalence in Morocco - a 10-Year Single-Center Study.

Clinical laboratory·2026
Same journal

Impact of Inactivated SARS-CoV-2 Vaccines on Serum Glycan Profiles and Protein N-Glycosylation.

Clinical laboratory·2026
Same journal

Albumin Concentration Associates Linearly with Unfavorable Outcomes at Three Months Post-Acute Ischemic Stroke in Koreans.

Clinical laboratory·2026
Same journal

Prognostic Value of the Blood Urea Nitrogen-to-Albumin Ratio for ICU Mortality in Cardiogenic Shock Patients: Evidence from the MIMIC-IV Database.

Clinical laboratory·2026
See all related articles

Cancer development involves three key gene groups: oncogenes promote tumor growth, tumor suppressor genes halt mutated cell proliferation, and mutator genes maintain genome integrity. Understanding these genetic factors is crucial for oncology advancements.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Cancer origin and spread are influenced by three primary gene groups: oncogenes, tumor suppressor genes, and mutator genes.
  • Proto-oncogenes, the normal form of oncogenes, can initiate malignant growth upon mutation.
  • Tumor suppressor genes require mutations in both alleles to inactivate their growth-inhibiting function, with a predisposition involving one pre-existing mutation.

Discussion:

  • Mutator genes are essential for genome integrity; their functional loss increases DNA replication errors, potentially leading to mutations in oncogenes or tumor suppressor genes.
  • Tumor-modifier genes are implicated in the development or prevention of environmentally influenced cancers and may explain incomplete penetrance in hereditary tumors.
  • Molecular diagnostics for these genes offer enhanced opportunities in oncology research and clinical practice.

Related Experiment Videos

Key Insights:

  • Oncogenes drive tumor cell growth independently of the tissue environment.
  • Tumor suppressor genes act as a brake on mutated cell proliferation, requiring biallelic inactivation.
  • Mutator genes' loss of function accelerates mutation rates, contributing to tumorigenesis.

Outlook:

  • Further research into tumor-modifier genes could elucidate mechanisms of environmentally induced cancers and hereditary tumor penetrance.
  • Molecular diagnostic advancements will improve our understanding and treatment of various cancers.
  • Identifying and characterizing these gene groups is fundamental for progress in cancer research and personalized oncology.